elexis AG focuses consistently on market and technology leadership
Wenden, 1. July 2021 – elexis AG is strategically focusing on the expansion of global growth markets in which innovation and market leadership has already been achieved in a stable manner and is selling Hekuma GmbH to the Dürr Group as part of this strategy. With this transaction, the Dürr Group is accelerating the expansion of its automation business in medical technology. It is therefore only logical that the Dürr Group should acquire 100% of the German mechanical engineering company Hekuma, which has sales of around € 40 million, on July 1, 2021. The company is one of the leading suppliers of automatic systems for the large-scale production of disposable plastic products used in medication, diagnostics, and laboratory technology. Hekuma's product range is an excellent complement to the medtech offerings of Teamtechnik, an automation specialist that also belongs to Dürr. Dürr acquired a majority stake in Teamtechnik in February, and this acquisition forms the platform for the company's targeted growth in the medical technology sector.
Dr Rolf Merte, CEO of elexis AG: "20 years ago, the decision of a diversified product portfolio as well as positioning in diversified markets was the right decision for our elexis. However, our new strategy is to focus on the markets where we have already achieved innovation and market leadership in a stable manner with our global presence with our high-tech products and to expand our spectrum vertically upwards and also horizontally there. In our group with HEKUMA we have not been able to leverage the synergies that are now possible through the DÜRR Group. We are pleased that HEKUMA, with its excellent management team and its high-tech products, will now be included in a global infrastructure and will have the chance to grow successfully much faster.”
"With the acquisition of Hekuma, we are taking the next logical step to build a leading competence centre for automation in medical device production under the Teamtechnik umbrella," said Dr Jochen Weyrauch, who as deputy CEO of Dürr AG is responsible for the medtech automation business. Hekuma and Teamtechnik systems are used, for example, to produce inhalers, injectors, blood collection tubes, pipette tips and infusion sets in quantities of several million per year. The world market for such disposable medical products is growing by about 8 % per year. The main reasons for this are the growth of the world population, rising life expectancy and the increasing quality of medical care.”
Hekuma GmbH, based in Hallbergmoos near Munich, Germany, employs around 180 people. Following successful restructuring in previous years, the company expects a positive operating result in 2021 and successive increases in earnings in the coming years. Since its foundation in 1974, Hekuma has installed around 5,000 systems worldwide. Hekuma systems work in the environment of injection moulding machines. They remove freshly moulded plastic parts, for example trays, vials, and sleeves, and add further plastic parts to these in an automated assembly process to form products or preliminary products. This is often followed by further assembly and testing steps, which Teamtechnik serves with its systems. Therefore, the combination of Teamtechnik and Hekuma enables Dürr to cover a large part of the automated value creation in medical device production. In addition, the customer base is growing because there is hardly any overlap in the customer bases of Hekuma and Teamtechnik.
In addition to the medical technology sector, which accounts for a good 50 % of turnover, Hekuma also supplies the automotive industry (25 % share of turnover). It produces, for example, ABS and sensor housings, plug connections or parts for transmission electronics on Hekuma equipment. Plastic elements for personal care products are also produced with the help of Hekuma technology, such as parts for razors or electric toothbrushes.
Under the umbrella of the Dürr Group, Hekuma will benefit from synergies, for example in purchasing, sales and service. Especially in the large markets of China and North America, Hekuma's customer access should improve. In addition, Hekuma and Teamtechnik together have a broader and more attractive range of products.
The closing of the transaction is still subject to approval by the competent antitrust authority.
Pictures of this press release are available on request.
Phone.: +49 2762 / 612 - 130
Fax: +49 2762 / 612 - 135